0001209191-24-001777.txt : 20240117
0001209191-24-001777.hdr.sgml : 20240117
20240117170943
ACCESSION NUMBER: 0001209191-24-001777
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240115
FILED AS OF DATE: 20240117
DATE AS OF CHANGE: 20240117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schiller Mark C.
CENTRAL INDEX KEY: 0002007659
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 24539256
MAIL ADDRESS:
STREET 1: C/O KEZAR LIFE SCIENCES, INC.
STREET 2: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2024-01-15
0
0001645666
Kezar Life Sciences, Inc.
KZR
0002007659
Schiller Mark C.
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Legal Officer
Common Stock
39695
D
Employee Stock Option (right to buy)
2.28
2029-04-14
Common Stock
50000
D
Employee Stock Option (right to buy)
2.28
2029-09-05
Common Stock
25000
D
Employee Stock Option (right to buy)
2.28
2030-01-11
Common Stock
52500
D
Employee Stock Option (right to buy)
2.28
2031-01-07
Common Stock
110000
D
Employee Stock Option (right to buy)
2.28
2032-01-04
Common Stock
130000
D
Employee Stock Option (right to buy)
2.28
2033-01-07
Common Stock
165000
D
Employee Stock Option (right to buy)
0.93
2034-01-06
Common Stock
250000
D
Includes 30,000 restricted stock units ("RSUs"). The RSUs will vest in two equal installments on July 2, 2024 and July 2, 2025, subject to the Reporting Person continuing to provide service through each such date.
Fully vested and exercisable.
One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.
One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing
to provide service through each such date.
One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 8, 2023, subject to the Reporting Person continuing to provide service through each such date.
One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 7, 2024, subject to the Reporting Person continuing to provide service through each such date.
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Marc Belsky, Attorney-in-Fact
2024-01-17
EX-24
2
poa.txt
POA DOCUMENT
Exhibit 24
POWER OF ATTORNEY
(For Executing Forms 3, 4 and 5)
Know all by these presents, that the undersigned hereby constitutes and
appoints each of Christopher Kirk, Marc Belsky and Andrew Basham of Kezar Life
Sciences, Inc. (the "Company"), signing individually, the undersigned's true and
lawful attorneys-in fact and agents to:
(1) Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission (the "SEC"), Forms 3, 4 and
5 (including amendments thereto and joint filing agreements in connection
therewith) in accordance with Section 16 of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and the rules thereunder, in the undersigned's
capacity as an officer, director or beneficial owner of more than 10% of a
registered class of securities of the Company;
(2) Do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to prepare and execute any such Forms 3, 4 or 5
(including amendments thereto and joint filing agreements in connection
therewith) and file such forms with the SEC and any stock exchange,
self-regulatory association or any similar authority; and
(3) Take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required of the undersigned, it being
understood that the documents executed by the attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as the attorney-in-fact may approve in the
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, and their
substitutes, in serving in such capacity at the request of the undersigned, are
not assuming (nor is the Company assuming) any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the Company and the foregoing attorneys-in fact or (c) as to any
attorney-in-fact individually, until such attorney-in-fact is no longer employed
by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.
Date: January 8, 2024
/s/ Mark Schiller
Mark Schiller